OpenVSafe by OpenVAERS
Search V-safe

755-12927-39746

2 vaccinations 3 coded responses 18 check-ins 3 free-text entries 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
100 / NY
Registered
2021-05-31
Relationship
Self
Race
White
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-05-27
    Dose 1 — Pfizer-BioNTech
  2. 2021-05-31
    Registered in v-safe
  3. 2021-05-31
    Survey response — days 1–6 daily, dose 1
    MedDRA: Vaginal haemorrhage — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Vaginal bleeding
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-05-31
    Report sent to call center — days 1–6 daily, dose 1
    Get care from a doctor or other healthcare professional
    1 call case(s)
  5. 2021-06-01
    Survey response — days 1–6 daily, dose 1
    MedDRA: Vaginal haemorrhage — Feeling: Good
    Free text: Vaginal blood spotting
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-06-03
    Survey response — day 7, dose 1
    MedDRA: Vaginal haemorrhage — Feeling: Good
    Free text: Vaginal spotting
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-06-03
    Call successful
    Participant prefers to complete VAERS report online
  8. 2021-06-10
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  9. 2021-06-17
    Dose 2 — Pfizer-BioNTech
  10. 2021-06-19
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-06-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2021-06-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  13. 2021-06-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-06-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  15. 2021-06-24
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  16. 2021-07-01
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-07-10
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-07-16
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-07-26
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-07-31
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-09-16
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-12-16
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  23. 2022-06-17
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-05-27Pfizer-BioNTech
22021-06-17Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2021-05-31 Successful
2021-06-03
 Participant prefers to complete VAERS report online

Free text

Release 8 — days 1–6 daily, dose 1

2021-05-31

Systemic reaction (other): Vaginal bleeding

2021-06-01

Systemic reaction (other): Vaginal blood spotting

Release 8 — day 7, dose 1

2021-06-03

Systemic reaction (other): Vaginal spotting

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SROVaginal haemorrhage ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…